Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Increase in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 49,200 shares, a growth of 693.5% from the February 28th total of 6,200 shares. Based on an average daily volume of 1,280,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.2% of the company’s stock are short sold.

Bioxytran Trading Up 3.3 %

Shares of BIXT traded up $0.00 on Thursday, reaching $0.16. The company’s stock had a trading volume of 215,994 shares, compared to its average volume of 295,877. Bioxytran has a twelve month low of $0.06 and a twelve month high of $0.21. The stock has a market capitalization of $13.66 million, a PE ratio of -15.50 and a beta of 2.00. The firm has a fifty day moving average of $0.10 and a 200-day moving average of $0.10.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.